title: The crisis in access to essential medicines in India: key issues which call for action.
abstract: The government is planning to introduce free generic and essential medicines in public health facilities. Most people in India buy healthcare from the private sector, a compulsion that accounts for a high proportion of healthcare-related expenditure. To reduce the burden of healthcare costs, the government must improve availability and affordability of generic and essential medicines in the market. It can do so because India's large pharmaceutical industry is a major source of generic medicines worldwide. In this article, we discuss three factors that have impeded access to generic and essential medicines: (1) mistaken notions among policymakers, prescribers and patients about branded drugs and generic drugs in India; (2) high prices of medicines due to the progressive dismantling of the system of regulation of medicine prices, and (3) a drug approval and regulatory system that allows medicines (including fixed dose combinations) of doubtful efficacy, rationale, safety and public health relevance to dominate the market at the cost of access to affordable generic and essential medicines. The consequences of ill-health and wasted expenditure on drugs raise issues of public health ethics.Improving access to essential medicines in India is an urgent public health and ethical imperative. This should include improved public provisioning, a system of regulation of drug prices, and an evidence-based drug approval process.
authors.affiliation: Department of Medicine, Himalayan Institute of Medical Sciences, Jolly Grant, Dehradun, Uttarakhand 248 140 INDIA. e-mail: anuragb17@gmail.com.
authors.forename: Anurag
authors.initials: A
authors.lastname: Bhargava
authors.forename: S P
authors.initials: SP
authors.lastname: Kalantri
mesh_terms: D001294:Attitude to Health; D016527:Drug Costs / Q000941:ethics* / Q000331:legislation & jurisprudence*; D018954:Drugs, Essential / Q000191:economics*; D016568:Drugs, Generic / Q000191:economics*; D006297:Health Services Accessibility / Q000191:economics* / Q000941:ethics*; D006801:Humans; D007194:India
chemical_list: D018954:Drugs, Essential; D016568:Drugs, Generic